Biocon Biologics CEO Shreehas Tambe says Bmab 1200 will strengthen its immunology franchise, enabling it to offer an affordable and effective treatment option for patients impacted by autoimmune diseases
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
